The Financial Burden of Cancer: Financial Ratio Analysis

被引：0
作者：
Radion Svynarenko
Qun Zhang
Hyungsoo Kim
机构：
[1] University of Kentucky,Department of Family Sciences
[2] Institute of Social and Political Psychology,undefined
来源：
Journal of Family and Economic Issues | 2019年 / 40卷
关键词：
Cancer; Financial status; Liquidity; Solvency; Investment; Financial strain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Using nine biannual waves (1998–2014) from the Health and Retirement Study, this study employed fixed-effects models to estimate the relationship between cancer and changes in financial status, measured by liquidity, solvency, and investment ratios. Results show that cancer survivors in the initial stage of cancer care increased their emergency fund equivalent to 15 days of living expenses, along with an increase in their debt to asset ratio by 0.8%, and a decrease of investment asset to net worth ratio by 0.4%. Furthermore, two additional years of post-cancer care and rehabilitation lead to an increase of five more days in emergency cash need and a decrease in investment asset to net worth ratio by 0.3%.
引用
收藏
页码：165 / 179
页数：14
相关论文
共 169 条
[1]  
Arozullah AM(2004)The financial burden of cancer: Estimates from a study of insured women with breast cancer Journal of Supportive Oncology 2 271-278
[2]  
Calhoun EA(2013)Borrowing to cope with adverse health events: Liquidity constraints, insurance coverage, and unsecured debt Health Economics 22 1177-1198
[3]  
Wolf M(2004)Assessing the baby boomers’ financial wellness using financial ratios and a subjective measure Family and Consumer Sciences Research Journal 32 321-348
[4]  
Finley DK(2001)Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer Journal of the National Cancer Institute 93 447-455
[5]  
Fitzner KA(2010)Families at financial risk due to high ratio of out-of-pocket health care expenditures to total income Journal of Health Care or the Poor and Underserved 21 691-703
[6]  
Heckinger EA(2016)Comparison of treatment costs for breast cancer, by tumor stage and type of service American Health Drug Benefits 9 23-32
[7]  
Bennett CL(1990)Risk aversion and the propensities for self-insurance and self-protection Southern Economic Journal 57 458-467
[8]  
Babiarz P(2002)Estimating health care costs related to cancer treatment from SEER-medicare data Medical Care 40 104-117
[9]  
Widdows R(2009)The costs of treating breast cancer in the US Pharmacoeconomics 27 199-209
[10]  
Yilmazer T(2013)Cost consequences of the 340B drug discount program The Journal of the American Medical Association 309 1995-1996
12345678910